IRB Policies and Procedures

To request any of the below IRB policies, please call the IRB Office at (321) 841-5895 

IRB Structure 

  • Ethical Principles 0330-1017
  • IRB Membership and Structure 0330-1013
  • IRB Authority and Jurisdiction 0330-1005
  • Use of a Single IRB of Record 0330-1023

Types Of IRB Review

  • Compassionate Use/Treatment Use/Expanded Access of Investigational Drug or Device 0330-1012
  • Emergency Use of Investigational Drugs and Devices 0330-1010
  • Exempt Review 0330-1004
  • Expedited Review 0330-1003
  • HUD Policy 0330-1006

IRB processes

  • Advertising, Recruiting and Media Contact for Research Subjects 0330-1021
  • Amendment Review Process 0330-1008
  • Continuing Review Process 0330-1007
  • Informed Consent Process 0330-1002
  • New Protocol Submission 0330-1014
  • Reporting Serious Adverse Events 0330-1000
  • Protocol Deviations/Violations/Non-compliance 0330-1001
  • Study Closure, Termination or Suspension of Research 0330-1019
  • Reports of Noncompliance or Complaints 0330-1009
  • IRB Process for Receiving Complaints 0330-1009
  • Translation of Study Documents 0330-1022

Vulnerable Population

  • Children in Research Including Unmarried Pregnant Minors, Unmarried Minor Mothers, Married Minors, and Emancipated Minors 0330-1011
  • Research Involving Pregnant Women, Fetuses and Neonates 0330-1016
  • Research Involving Prisoners 0330-1020
  • Research On Decedents 0330-1018